lobbying_activities: 1883296

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1883296	57d151cb-03d7-4af5-87f7-9aeb168768fa	Q3	BLUESTONE STRATEGIES, LLC	400658980	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2016	third_quarter	PHA	Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; Specialty Drug Issues; S. 1413, RX Abuse and Prevention; and S.1913, Pharmacy Lock-In	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2016-10-18T15:25:03.397000-04:00